Literature DB >> 11686210

The CCK-2 receptor is located on the ECL cell, but not on the parietal cell.

I Bakke1, G Qvigstad, A K Sandvik, H L Waldum.   

Abstract

BACKGROUND: The interrelationship between histamine and gastrin in the physiological regulation of gastric acid secretion is still a matter of dispute. CCK-2 receptors are located on enterochromaffin-like (ECL) cells in corpus mucosa and gastrin stimulates acid production by releasing histamine from the ECL cells, which in turn stimulates the parietal cells. Whether parietal cells also possess gastrin receptors of physiological significance is unclear. The aim of the present study was to localize the CCK-2 receptor cellularly and concomitantly demonstrate a gastrin receptor response (histamine release).
METHODS: Fluorescein labelled cholecystokinin-8 (Fluo-CCK-8) was added to the arterial infusion to totally isolated, vascularly perfused rat stomachs to a final concentration of 130 pmol L(-1) for 1 min, either alone or along with 520 nmol(-1) CCK-8 after 10-min pre-perfusion with CCK-8. Immediately after the Fluo-CCK-8 had reached the oxyntic mucosa, biopsies were taken and the binding sites were localized by double immunohistochemistry combined with the tyramide signal amplification (TSA) technique. Venous histamine was measured before and during stimulation.
RESULTS: Fluo-CCK-8 (130 pM) evoked histamine release, and binding sites were found in the basal part of corpus mucosa, co-localized with histidine decarbocylase (HDC) immunoreactive ECL cells. No binding of Fluo-CCK was found in the mid-glandular region of corpus, dominated by parietal cells. Binding of Fluo-CCK-8 was abolished by concomitant perfusion with excess CCK-8.
CONCLUSION: Fluo-CCK-8 given to isolated rat stomachs in a physiological concentration binds to CCK-2 receptors on ECL cells and causes histamine release, whereas no binding of Fluo-CCK-8 to parietal cells was found.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686210     DOI: 10.1080/00365520152584734

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  21 in total

1.  Oral proton-pump inhibitors and step-down therapy for nonulcer dyspepsia: is this the right approach?

Authors:  Helge L Waldum; Tom C Martinsen; Oyvind Hauso; Gunnar Qvigstad
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

Review 2.  Antiulcer drugs and gastric cancer.

Authors:  Helge L Waldum; Bjørn Gustafsson; Reidar Fossmark; Gunnar Qvigstad
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

3.  Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.

Authors:  Malcolm Boyce; Frans van den Berg; Toni Mitchell; Kate Darwin; Steve Warrington
Journal:  Eur J Clin Pharmacol       Date:  2016-10-29       Impact factor: 2.953

4.  Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.

Authors:  Sinju Sundaresan; Anthony J Kang; Michael M Hayes; Eun-Young K Choi; Juanita L Merchant
Journal:  Gut       Date:  2016-02-09       Impact factor: 23.059

5.  Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type.

Authors:  Kurt Borch; Bo Ahrén; Håkan Ahlman; Sture Falkmer; Göran Granérus; Lars Grimelius
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

Review 6.  Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach.

Authors:  Helge L Waldum; Øyvind Hauso; Øystein F Sørdal; Reidar Fossmark
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

7.  G and D cells in rat antral mucosa: an immunoelectron microscopic study.

Authors:  Feng-Peng Sun; Yu-Gang Song
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 8.  Animal models to study the role of long-term hypergastrinemia in gastric carcinogenesis.

Authors:  Reidar Fossmark; Gunnar Qvigstad; Tom Chr Martinsen; Øyvind Hauso; Helge L Waldum
Journal:  J Biomed Biotechnol       Date:  2010-11-24

Review 9.  Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia.

Authors:  Reidar Fossmark; Gunnar Qvigstad; Helge-L Waldum
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

10.  Control of gastric acid secretion in somatostatin receptor 2 deficient mice: shift from endocrine/paracrine to neurocrine pathways.

Authors:  Chun-Mei Zhao; Vicente Martinez; Laura Piqueras; Lixin Wang; Yvette Taché; Duan Chen
Journal:  Endocrinology       Date:  2007-11-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.